Skip to main content
Top
Published in: Diabetologia 9/2017

Open Access 01-09-2017 | Article

Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study

Authors: Helen R. Murphy, Ruth Bell, Cher Cartwright, Paula Curnow, Michael Maresh, Margery Morgan, Catherine Sylvester, Bob Young, Nick Lewis-Barned

Published in: Diabetologia | Issue 9/2017

Login to get access

Abstract

Aims/hypothesis

The aim of this prospective nationwide study was to examine antenatal pregnancy care and pregnancy outcomes in women with type 1 and type 2 diabetes, and to describe changes since 2002/2003.

Methods

This national population-based cohort included 3036 pregnant women with diabetes from 155 maternity clinics in England and Wales who delivered during 2015. The main outcome measures were maternal glycaemic control, preterm delivery (before 37 weeks), infant large for gestational age (LGA), and rates of congenital anomaly, stillbirth and neonatal death.

Results

Of 3036 women, 1563 (51%) had type 1, 1386 (46%) had type 2 and 87 (3%) had other types of diabetes. The percentage of women achieving HbA1c < 6.5% (48 mmol/mol) in early pregnancy varied greatly between clinics (median [interquartile range] 14.3% [7.7–22.2] for type 1, 37.0% [27.3–46.2] for type 2). The number of infants born preterm (21.7% vs 39.7%) and LGA (23.9% vs 46.4%) were lower for women with type 2 compared with type 1 diabetes (both p < 0.001). The prevalence rates for congenital anomaly (46.2/1000 births for type 1, 34.6/1000 births for type 2) and neonatal death (8.1/1000 births for type 1, 11.4/1000 births for type 2) were unchanged since 2002/2003. Stillbirth rates are almost 2.5 times lower than in 2002/2003 (10.7 vs 25.8/1000 births for type 1, p = 0.0012; 10.5 vs 29.2/1000 births for type 2, p = 0.0091).

Conclusions/interpretation

Stillbirth rates among women with type 1 and type 2 diabetes have decreased since 2002/2003. Rates of preterm delivery and LGA infants are lower in women with type 2 compared with type 1 diabetes. In women with type 1 diabetes, suboptimal glucose control and high rates of perinatal morbidity persist with substantial variations between clinics.

Data availability

Further details of the data collection methodology, individual clinic data and the full audit reports for healthcare professionals and service users are available from http://​content.​digital.​nhs.​uk/​npid.
Literature
1.
go back to reference Persson M, Norman M, Hanson U (2009) Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 32:2005–2009CrossRefPubMedPubMedCentral Persson M, Norman M, Hanson U (2009) Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care 32:2005–2009CrossRefPubMedPubMedCentral
2.
go back to reference Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328:915CrossRefPubMedPubMedCentral Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328:915CrossRefPubMedPubMedCentral
3.
go back to reference Macintosh MC, Fleming KM, Bailey JA et al (2006) Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333:177CrossRefPubMedPubMedCentral Macintosh MC, Fleming KM, Bailey JA et al (2006) Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 333:177CrossRefPubMedPubMedCentral
4.
go back to reference Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH (2002) Macrosomia despite good glycaemic control in type I diabetic pregnancy; results of a nationwide study in the Netherlands. Diabetologia 45:1484–1489CrossRefPubMed Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH (2002) Macrosomia despite good glycaemic control in type I diabetic pregnancy; results of a nationwide study in the Netherlands. Diabetologia 45:1484–1489CrossRefPubMed
5.
go back to reference Klemetti M, Nuutila M, Tikkanen M, Kari MA, Hiilesmaa V, Teramo K (2012) Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989-2008. Diabetologia 55:2327–2334CrossRefPubMed Klemetti M, Nuutila M, Tikkanen M, Kari MA, Hiilesmaa V, Teramo K (2012) Trends in maternal BMI, glycaemic control and perinatal outcome among type 1 diabetic pregnant women in 1989-2008. Diabetologia 55:2327–2334CrossRefPubMed
6.
go back to reference Confidential Enquiry into Maternal and Child Health (2005) Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. CEMACH, London Confidential Enquiry into Maternal and Child Health (2005) Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. CEMACH, London
7.
go back to reference NICE guideline 63 (2008) Diabetes in pregnancy. Management of diabetes and its complications from the pre-conception to the postnatal period. Available from www.nice.org. Accessed 26 Nov 2016 NICE guideline 63 (2008) Diabetes in pregnancy. Management of diabetes and its complications from the pre-conception to the postnatal period. Available from www.​nice.​org. Accessed 26 Nov 2016
9.
go back to reference Murphy HR, Bell R, Holt RI et al (2013) The National Pregnancy in Diabetes Audit: measuring the quality of diabetes pregnancy care. Diabet Med 30:1014–1016CrossRefPubMed Murphy HR, Bell R, Holt RI et al (2013) The National Pregnancy in Diabetes Audit: measuring the quality of diabetes pregnancy care. Diabet Med 30:1014–1016CrossRefPubMed
10.
go back to reference Office of the Deputy Prime Minister (2004) The English indices of deprivation 2004 (revised). Office of the Deputy Prime Minister, London Office of the Deputy Prime Minister (2004) The English indices of deprivation 2004 (revised). Office of the Deputy Prime Minister, London
13.
go back to reference Bestwick JP, Huttly WJ, Morris JK, Wald NJ (2014) Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women. PLoS One 9:e89354CrossRefPubMedPubMedCentral Bestwick JP, Huttly WJ, Morris JK, Wald NJ (2014) Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women. PLoS One 9:e89354CrossRefPubMedPubMedCentral
14.
go back to reference Murphy HR, Roland JM, Skinner TC et al (2010) Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care 33:2514–2520CrossRefPubMedPubMedCentral Murphy HR, Roland JM, Skinner TC et al (2010) Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care 33:2514–2520CrossRefPubMedPubMedCentral
15.
go back to reference Murphy HR, Elleri D, Allen JM et al (2012) Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia 55:282–293CrossRefPubMed Murphy HR, Elleri D, Allen JM et al (2012) Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia 55:282–293CrossRefPubMed
16.
go back to reference Goudie RJ, Lunn D, Hovorka R, Murphy HR (2014) Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different. Diabetes Care 37:e121–e122CrossRefPubMed Goudie RJ, Lunn D, Hovorka R, Murphy HR (2014) Pharmacokinetics of insulin aspart in pregnant women with type 1 diabetes: every day is different. Diabetes Care 37:e121–e122CrossRefPubMed
17.
go back to reference Holman N, Bell R, Murphy H, Maresh M (2014) Women with pre-gestational diabetes have a higher risk of stillbirth at all gestations after 32 weeks. Diabet Med 31:1129–1132CrossRefPubMed Holman N, Bell R, Murphy H, Maresh M (2014) Women with pre-gestational diabetes have a higher risk of stillbirth at all gestations after 32 weeks. Diabet Med 31:1129–1132CrossRefPubMed
18.
go back to reference Flenady V, Wojcieszek AM, Middleton P et al (2016) Stillbirths: recall to action in high-income countries. Lancet 387:691–702CrossRefPubMed Flenady V, Wojcieszek AM, Middleton P et al (2016) Stillbirths: recall to action in high-income countries. Lancet 387:691–702CrossRefPubMed
19.
go back to reference Stillbirth Collaborative Research Network Writing Group (2011) Association between stillbirth and risk factors known at pregnancy confirmation. JAMA 306:2469–2479CrossRef Stillbirth Collaborative Research Network Writing Group (2011) Association between stillbirth and risk factors known at pregnancy confirmation. JAMA 306:2469–2479CrossRef
20.
go back to reference Familiari A, Scala C, Morlando M, Bhide A, Khalil A, Thilaganathan B (2016) Mid-pregnancy fetal growth, uteroplacental doppler indices and maternal demographic characteristics: role in prediction of stillbirth. Acta Obstet Gynecol Scand 95:1313–1318CrossRefPubMed Familiari A, Scala C, Morlando M, Bhide A, Khalil A, Thilaganathan B (2016) Mid-pregnancy fetal growth, uteroplacental doppler indices and maternal demographic characteristics: role in prediction of stillbirth. Acta Obstet Gynecol Scand 95:1313–1318CrossRefPubMed
21.
go back to reference Smith GC (2016) Screening and prevention of stillbirth. Best Pract Res Clin Obstet Gynaecol 10:1–12 Smith GC (2016) Screening and prevention of stillbirth. Best Pract Res Clin Obstet Gynaecol 10:1–12
22.
go back to reference Temple R, Murphy H (2010) Type 2 diabetes in pregnancy: an increasing problem. Best Pract Res 24:591–603CrossRef Temple R, Murphy H (2010) Type 2 diabetes in pregnancy: an increasing problem. Best Pract Res 24:591–603CrossRef
23.
go back to reference Balsells M, Garcia-Patterson A, Gich I, Corcoy R (2009) Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 94:4284–4291CrossRefPubMed Balsells M, Garcia-Patterson A, Gich I, Corcoy R (2009) Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 94:4284–4291CrossRefPubMed
24.
go back to reference Feig DS, Asztalos E, Corcoy R et al (2016) CONCEPTT: continuous glucose monitoring in women with type 1 diabetes in pregnancy trial: a multi-center, multi-national, randomized controlled trial—study protocol. BMC Pregnancy Childbirth 16:167CrossRefPubMedPubMedCentral Feig DS, Asztalos E, Corcoy R et al (2016) CONCEPTT: continuous glucose monitoring in women with type 1 diabetes in pregnancy trial: a multi-center, multi-national, randomized controlled trial—study protocol. BMC Pregnancy Childbirth 16:167CrossRefPubMedPubMedCentral
25.
go back to reference Stewart ZA, Wilinska ME, Hartnell S et al (2016) Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med 375:644–654CrossRefPubMed Stewart ZA, Wilinska ME, Hartnell S et al (2016) Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med 375:644–654CrossRefPubMed
26.
go back to reference Teramo K, Kari MA, Eronen M, Markkanen H, Hiilesmaa V (2004) High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia 47:1695–1703CrossRefPubMed Teramo K, Kari MA, Eronen M, Markkanen H, Hiilesmaa V (2004) High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies. Diabetologia 47:1695–1703CrossRefPubMed
27.
go back to reference Conde-Agudelo A, Bird S, Kennedy SH, Villar J, Papageorghiou AT (2015) First- and second-trimester tests to predict stillbirth in unselected pregnant women: a systematic review and meta-analysis. BJOG 122:41–55CrossRefPubMed Conde-Agudelo A, Bird S, Kennedy SH, Villar J, Papageorghiou AT (2015) First- and second-trimester tests to predict stillbirth in unselected pregnant women: a systematic review and meta-analysis. BJOG 122:41–55CrossRefPubMed
28.
go back to reference Chaiworapongsa T, Romero R, Korzeniewski SJ et al (2013) Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol 208(287):e1–e15 Chaiworapongsa T, Romero R, Korzeniewski SJ et al (2013) Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. Am J Obstet Gynecol 208(287):e1–e15
Metadata
Title
Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study
Authors
Helen R. Murphy
Ruth Bell
Cher Cartwright
Paula Curnow
Michael Maresh
Margery Morgan
Catherine Sylvester
Bob Young
Nick Lewis-Barned
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4314-3

Other articles of this Issue 9/2017

Diabetologia 9/2017 Go to the issue